Medtech titan St. Jude Medical (NYSE:STJ) won FDA premarket approval for its Cool Flex cardiac ablation system with indication to treat irregular heart rhythms.
Ablation
Renal denervation ‘highly unlikely’ for hypertension, says Medtronic study insider
The future of renal denervation in treatment of hypertension is shaky at best, according to 1 of the principal investigators involved with Medtronic’s disappointing clinical trial.
Medtronic’s miss muddles the renal denervation landscape | MassDevice.com On Call
Medtronic revisits atrial fibrillation ablation with VICTORY AF study
AtriCure acquires Estech’s ablation systems in $34M deal
Mederi Therapeutics closes $19M funding round
Connecticut-based Mederi Therapeutics closed a Series B financing round, bringing in $18.5 million through sales of preferred stock and venture debt.
Funding was led by Acadia Woods Partners, LLC, Respiratory Diagnostics Inc., and Horizon Technology Finance, Mederi reported.
Medtronic’s new renal denervation trial examines less-severe hypertension
Renal denervation may help the heart on its own | MassDevice.com On Call
MASSDEVICE ON CALL — Renal denervation, studied primarily in treatment of hypertension, may product benefits to heart health independent of those generated by lowering blood pressure, according to researchers reporting results from a small study.
The clinicians cautioned that the results are very early and need confirmation from a larger study, but were worked up about the findings.
Medtronic touts E.U., Aussie wins for next-gen Symplicity renal denervation components
Cali startup Apama Medical lands $3.2M Series A-1
California startup Apama Medical raised $3.2 million in a Series A-1 financing round in support of a catheter-based technology that the company says is "vastly superior" in treatment of atrial fibrillation.
The company offered few details about the device in the press release or on its minimal website, but noted that it hopes to enter an atrial fibrillation mapping and ablation market that it expects to reach $2 billion by 2017.